Moving from Basic Toward Systems Pharmacodynamic Models

被引:58
作者
Jusko, William J. [1 ]
机构
[1] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Buffalo, NY 14214 USA
关键词
pharmacokinetics; pharmacodynamics; pharmacometrics; systems pharmacology; indirect response models; dose response; mathematical model; preclinical pharmacokinetics; DRUG DEVELOPMENT; RESPONSE MODEL; RAT MODEL; PHARMACOKINETICS; TOLERANCE; KINETICS; OPPORTUNITIES; ARTHRITIS; DISEASE;
D O I
10.1002/jps.23590
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Building upon many classical foundations of pharmacology, a diverse array of mechanistic pharmacokinetic-pharmacodynamic (PK/PD) models have emerged based on mechanisms of drug action and primary rate-limiting or turnover processes in physiology. An array of basic models can be extended to handle various complexities including tolerance and can readily be employed as building blocks in assembling enhanced PK/PD or small systems models. Our corticosteroid models demonstrate these concepts as well as elements of horizontal and vertical integration of molecular to whole-body processes. The potential advantages and challenges in moving PK/PD toward systems models are described. (C) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association
引用
收藏
页码:2930 / 2940
页数:11
相关论文
共 54 条
[1]   In silico experiments of existing and hypothetical cytokine-diyected clinical trials using agent-based modeling [J].
An, G .
CRITICAL CARE MEDICINE, 2004, 32 (10) :2050-2060
[2]   PHARMACODYNAMIC MODELS OF NITROGLYCERIN-INDUCED HEMODYNAMIC TOLERANCE IN EXPERIMENTAL HEART-FAILURE [J].
BAUER, JA ;
FUNG, HL .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :816-823
[3]   Impact of pharmacometric reviews on new drug approval and labeling decisions - a survey of 31 new drug applications submitted between 2005 and 2006 [J].
Bhattaram, V. A. ;
Bonapace, C. ;
Chilukuri, D. M. ;
Duan, J. Z. ;
Garnett, C. ;
Gobburu, J. V. S. ;
Jang, S. H. ;
Kenna, L. ;
Lesko, L. J. ;
Madabushi, R. ;
Men, Y. ;
Powell, J. R. ;
Qiu, W. ;
Ramchandani, R. P. ;
Tornoe, C. W. ;
Wang, Y. ;
Zheng, J. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) :213-221
[4]   OPERATIONAL MODELS OF PHARMACOLOGICAL AGONISM [J].
BLACK, JW ;
LEFF, P .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1983, 220 (1219) :141-162
[5]   Feedback loops shape cellular signals in space and time [J].
Brandman, Onn ;
Meyer, Tobias .
SCIENCE, 2008, 322 (5900) :390-395
[6]   Applications of minimal physiologically-based pharmacokinetic models [J].
Cao, Yanguang ;
Jusko, William J. .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (06) :711-723
[7]  
Clark A.J., 1933, MODE ACTION DRUGS CE
[8]   COMPARISON OF 4 BASIC MODELS OF INDIRECT PHARMACODYNAMIC RESPONSES [J].
DAYNEKA, NL ;
GARG, V ;
JUSKO, WJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1993, 21 (04) :457-478
[9]   Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: Mechanistic pharmacodynamic model for dexamethasone effects in lewis rats with collagen-induced arthritis [J].
Earp, Justin C. ;
DuBois, Debra C. ;
Molano, Diana S. ;
Pyszczynski, Nancy A. ;
Almon, Richard R. ;
Jusko, William J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (02) :546-554
[10]   Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: Mechanistic disease progression model for the time course of collagen-induced arthritis in lewis rats [J].
Earp, Justin C. ;
DuBois, Debra C. ;
Molano, Diana S. ;
Pyszczynski, Nancy A. ;
Keller, Craig E. ;
Almon, Richard R. ;
Jusko, William J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (02) :532-545